Health News Archive - July 10, 2011
VENLO, The Netherlands and MELBOURNE, Australia, July 11, 2011 /PRNewswire/ -- - QIAGEN increases offer to shareholders of Cellestis Limited (CST:AU) pursuant to scheme of arrangement - Cellestis board of directors unanimously support[1] amended proposal offering its shareholders a 7% increase to A$3.80 per share from original offer of A$3.55 - Acquisition would provide QIAGEN with exclusive access to QuantiFERON(R) technology for high sensitivity, early disease detection not possible with other diagnostics QIAGEN N.V.

